- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- Analysis
- Focus Articles
- Related Articles2 new
- Instablogs
- StockTalks
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts1 new
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
DNDN Market Currents
more »
-
Friday 2:30 PM Shares of Dendreon (DNDN -5.1%) continue their descent today after Maxim initiates coverage with a sell rating, saying that Provenge faces logistic, manufacturing and competitive challenges that could impede sales growth.
5 Comments[Healthcare, On the Move]
- Thursday 11:22 AM Dendreon (DNDN) shares -10.3% after it confirms that the SEC has opened an investigation, which could be connected to lawsuits accusing the company of misleading investors over prostate-cancer treatment Provenge. [Healthcare, On the Move]
-
Thursday 9:10 AM Premarket gainers: VELT +11%. SHLD +10%. CTRP +9%. BYD +7%. GALE +6%. ONXX +6%. HLF +5%.
Losers: AAP -11%. DNDN -6%. [On the Move]
DNDN in Focus
more »
DNDN Related Articles
more »
DNDN News
more »
-
at CNBC.com (Tue, 4:39PM)
-
at CNBC.com (Thu, 2:29PM)
-
at MarketWatch.com (Thu, 1:44PM)
-
at MarketWatch.com (May 8, 2012)
-
at MarketWatch.com (May 8, 2012)
DNDN Press Releases and Filings
more »
-
Business Wire (Mon, 10:30AM)
-
Business Wire (Wed, 6:00PM)
-
Business Wire (May 7, 2012)
-
Business Wire (Apr 9, 2012)
-
Business Wire (Jan 5, 2012)
DNDN Latest Transcript
more »
DNDN Cramer
more »
DNDN Instablog posts
more »
DNDN vs. ETF Alternatives
Company Description
Dendreon Corporation (“Dendreon”, the “Company”, “we”, “us”, or “our”), is a biotechnology company focused on the discovery, development and commercialization of novel therapeutics that may significantly improve cancer treatment options for patients. Our product portfolio includes active... More